Advaxis receives $244.

Advaxis receives $244,479 QTDP credit for ADXS11-001 trial Advaxis, Inc., , the live, attenuated Listeria monocytogenes immunotherapy company was awarded a Qualifying Therapeutic Discovery Project credit from the government for ADXS11-001, the Company’s business lead immunotherapeutic construct totaling $244,479. Moore.Andrographis Research suggests that the herb andrographis includes a strong potential to control skin aging. It is extracted from the Andrographis herb. Pomegranate This herb offers punicalagins, punicalins, gallagic acid and ellagic acid. Even though some of these substances aren’t yet used commercially, all of them possess been found to be effective in neutralizing oxidants and free radicals.

Accellent to market Pittsburgh facility to Perryman Accellent Inc. , a wholly-owned subsidiary of Accellent Holdings Corp., provides entered into an agreement to sell its facility located outside of Pittsburgh in Houston just, Pennsylvania to The Perryman Company , also headquartered in Houston, Pennsylvania.